Annual EAU Congresses







EAU Section Meetings
Central European Meetings
South Eastern European Meetings
Annual EAUN Meetings

European Urology Residents Educational Programme
Regional Meetings
EMUC: European Multidisciplinary Meeting on Urological Cancers







Masterclasses
Other




Filters Reset

6652 results
Show filter +
×
organ
access
procedure
pathology

Loading results  

 Posters (6652)

P005: Molecular genetic alterations and their predictive values in superficial bladder cancer

By:Babayan A.1, Bashkatov S.2, Karyakin O.2, Teplov A.3, Golovashenko M.3, Zaletaev D.1, Nemtsova M.1
Institutes: 1Sechenov Moscow Medical Academy, Research Institute For Molecular Medicine, Moscow, 2Medical Radiology Research Centre, Department of Urology, Obninsk, 3Moscow Herzen Oncological Research Institute, Department of Urology, Moscow
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 28-11-2009
  • Views: 491
  • Nr: P005

P010: Assessment of quality of life (QOL) in treatment-naïve and cytokine-pretreated patients with advanced renal cell carcinoma (RCC) treated with pazopanib in a phase III double-blind, placebo-controlled trial

By:Hawkins R.1, Hodge R.2, Chen M.3, Neary M.P.3, Pickard A.S.4, Sternberg C.5, Ralph C.6
Institutes: 1University of Manchester, Faculty of Medical & Human Sciences, Manchester, 2Glaxosmithkline, Department of Oncology, Uxbridge, 3Glaxosmithkline, Department of Oncology, Collegeville, 4University of Illinois College of Pharmacy, Department of Pharmacy Practice, Chicago, 5San Camillo and Forlanini Hospital, Department of Medical Oncology, Rome, 6University of Manchester Paterson Institute for Cancer Research, Dept. of Oncology, Manchester
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 28-11-2009
  • Views: 505
  • Nr: P010

P001: Hypofractionation vs. conventional fractionation radiotherapy in patients with high risk prostate cancer: Early results of a phase III randomized study

By:Saracino B.1, Arcangeli S.1, Gomellini S.1, Petrongari M.G.1, Sentinelli S.2, Fowler J.3, Strigari L.4, Arcangeli G.1
Institutes: 1Ifo-"regina Elena", Dept. of Radiotherapy, Rome, 2Ifo-"regina Elena", Dept. of Pathology, Rome, 3University of Wisconsin, Dept. of Human Pathology and Medical Physics, Madison, 4Ifo-"regina Elena", Dept. of Medical Physics, Rome
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 28-11-2009
  • Views: 403
  • Nr: P001

P003: The first set of nomograms predicting late rectal toxicity in prostate cancer patients undergoing 3DCRT: Development and internal validation

By:Valdagni R.1, Kattan M.W.2, Rancati T.1, Yu C.2, Vavassori V.3, Fellin G.4, Bianchi C.5, Menegotti L.6, Monti A.7, Stasi M.8, Baccolini M.9, Fiorino C.10
Institutes: 1Fondazione Irccs - Istituto Nazionale Dei Tumori, Prostate Program, Milan, 2Cleveland Clinic Lerner College of Medicine, Health Sciences, Cleveland, 3Ospedale Di Circolo, Radiotherapy, Varese, 4Ospedale Santa Chiara, Radiotherapy, Trento, 5Ospedale Di Circolo, Medical Physics, Varese, 6Ospedale Santa Chiara, Medical Physics, Trento, 7Ospedale Sant'anna, Medical Physics, Como, 8Ordine Mauriziano, Medical Physics, Torino, 9Villa Maria Cecilia, Medical Physics, Lugo, 10Ospedale San Raffaele, Medical Physics, Milan
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 28-11-2009
  • Views: 263
  • Nr: P003

P008: A randomized prospective phase II study with Sorafenib (So) and Interleukin-2 (IL-2) versus So alone as first-line treatment in advanced renal cell cancer (RCC): ROSORC trial

By:Procopio G.1, Verzoni E.1, Bracarda S.2, Cascinu S.3, Manzoni M.1, Salvioni R.6, Bregni M.4, Celio L.1, Ortega C.5, Bajetta E.1
Institutes: 1Fondazione Irccs Istituto Nazionale Tumori, Oncologia 2, Milano, 2Ospedale Santa Maria Delle Misericordie, Oncologia, Perugia, 3Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I, Oncologia, Ancona, 4Istituto Scientifico S. Raffaele, Oncologia, Milano, 5Istituto Tumori, Oncologia, Candiolo, 6Fondazione Irccs Istituto Nazionale Tumori, Urologia, Milano
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 28-11-2009
  • Views: 247
  • Nr: P008

P014: [18F]-fluorocholine PET/CT for preoperative lymph node staging of prostate cancer. Preliminary results of a prospective study

By:Poulsen M.H.1, Bouchelouche K.2, Gerke O.2, Henrik H.2, Svolgaard B.3, Marcussen N.4, Svolgaard N.1, Ögren M.2, Vach W.5, Høilund-Carlsen P.F.2, Geertsen U.1, Walter S.1
Institutes: 1Odense University Hospital, Dept. of Urology, Odense, 2Odense University Hospital, Dept. of Nuclear Medicine, Odense, 3Odense University Hospital, Dept. of Radiology, Odense, 4Odense University Hospital, Dept. of Pathology, Odense, 5University of Southern Denmark, Dept. of Statistics, Odense
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 350
  • Nr: P014

P020: Prognostic factors of low volume prostate cancer in patients underwent radical prostatectomy

By:Alekseev B.1, Rusakov I.G.1, Vorobyev N.V.1, Frank G.A.2, Andreeva Y.2, Nyushko K.M.1, Chissov V.I.3
Institutes: 1Moscow Hertzen Oncology Institute, Dept. of Oncourology, Moscow, 2Moscow Hertzen Oncology Institute, Dept. of Pathology, Moscow, 3Moscow Hertzen Oncology Institute, Head of Institution, Moscow
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 367
  • Nr: P020

P027: Median 5 year follow-up of Iodine 125 brachytherapy (BT) as monotherapy in men aged 55 years and under with favorable prostate cancer

By:Gomez-Iturriaga A.1, Crook J.2, Lockwood G.2, Fleshner N.3
Institutes: 1Princess Margaret Hospital/university of Toronto, Radiation Oncology, Toronto, 2Princess Margaret Hospital/ University of Toronto, Dept. of Radiation Oncology, Toronto, 3Princess Margaret Hospital/ University of Toronto, Dept. of Urology, Toronto
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 345
  • Nr: P027

P032: Image guided intensive modulated radiosurgery boost combined with conformal radiotherapy prostate cancer patients

By:Urbańczyk H.A.1, Hawrylewicz L.2, Majewski W.1, Misztal L.2, Wesołowska I.2, Leszczyński W.2, Rembak-Szymkiewicz J.3, Ciechowicz J.4, Ślosarek K.2, Miszczyk L.1
Institutes: 1Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Dept. of Radiotherapy, Gliwice, 2Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Dept. of Radiotherapy Planning, Gliwice, 3Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Dept. of Radiology, Gliwice, 4Medical University In Łódź, Computer Laboratory, Łódź
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 352
  • Nr: P032

P036: Renal cysts: Imaging at contrast-enhanced ultrasound (CE-US) and correlation with computed tomography (CT)

By:García Rojo D.1, Ballesteros E.2, Malet A.2, Hannaoui N.3, Gonzale-Sala J.L.3, Vicente E.3, Darnell A.2, Abad C.3, Martos R.3, Prera A.3, Martin J.2, Prats J.3
Institutes: 1Consorci Hospitalari Parc Tauli, Servicio de Urologia, Sabadell, 2Hospital Sabadell, Dept. of Radiology, Sabadell, 3Hospital Sabadell, Dept. of Urology, Sabadell
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 361
  • Nr: P036

P067: P-38: Relationship with PSA and possible therapeutic target in prostate cancer

By:Fraile B.1, Rodriguez-Berriguete G.2, Vera R.2, Bouraoui Y.3, Martinez-Onsurbe P.4, Olmedilla G.4, Oueslati R.3, Paniagua R.2, Royuela M.2
Institutes: 1University of Alcala, Dept. of Cell Biology and Genetics, Alcala De Henares. Madrid, 2University of Alcala, Dept. of Cell Biology and Genetics, Alcala De Henares. Madrid, 3Faculté Des Science De Bizerte, Unité D'immunologie Microbiologie, Bizerte, 4Principe De Asturias Hospital, Dept. of Pathology, Alcala De Henares. Madrid
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 274
  • Nr: P067

P075: Quality of life in patients undergoing active surveillance: Early results

By:Spatuzzi A.L.1, Valdagni R.1, Villa S.2, Bellardita L.1, Giganti M.O.1, Rancati T.1, Nicolai N.3, Stagni S.3, Bedini N.2, Catena L.4, Procopio G.4, Magnani T.1, Biasoni D.3, Torelli T.3, Valvo F.2, Catanzaro M.3, Visini R.1, Salvioni R.3, Donegani S.1
Institutes: 1Fondazione Irccs - Istituto Nazionale Dei Tumori, Prostate Program, Milan, 2Fondazione Irccs - Istituto Nazionale Dei Tumori, Radiotherapy, Milan, 3Fondazione Irccs - Istituto Nazionale Dei Tumori, Urology, Milan, 4Fondazione Irccs - Istituto Nazionale Dei Tumori, Medical Oncology, Milan
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 243
  • Nr: P075

P080: Sodium butyrate enema in the treatment of acute proctitis following 3dcrt in prostate cancer patients

By:Vavassori V.1, Brunetti G.2, San Romerio A.2, Maggio A.3, Fiorino C.3, Valvo F.4, Bedini N.4, Fellin G.5, Tomio L.5, Munoz F.6, Ricardi U.6, Cosentino D.7, Cazzaniga L.F.7, Della Bosca E.1, Magli A.8, Signor M.8, Rancati T.9, Valdagni R.9
Institutes: 1Ospedale Di Circolo, Dept. of Radiotherapy, Varese, 2Promefarm, -, Milano, 3Ospedale San Raffaele, Dept. of Medical Physics, Milano, 4Fondazione Irccs Istituto Nazionale Tumori, Dept. of Radiation Oncology, Milano, 5Ospedale Santa Chiara, Dept. of Radiation Oncology, Trento, 6Azienda Ospedaliera Molinette, Dept. of Radiation Oncology, Torino, 7Ospedale Sant’anna, Dept. of Radiation Oncology, Como, 8Ospedale S. Maria Della Misericordia, Dept. of Radiation Oncology, Udine, 9Fondazione Irccs Istituto Nazionale Tumori, Prostate Program, Scientific Directorate, Milano
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 278
  • Nr: P080

P094: Clinical factors associated with outcome in patients with advanced renal cell carcinoma treated with sunitinib

By:Karadimou A.1, Lampamki S.2, Lainakis G.3, Papazisis K.4, Andreadis Ch.4, Xanthakis I.5, Christodoulou C.6, Syrigos K.7, Papandreou C.8, Fountzilas G.5, Dimopoulos M.A.3, Bamias A.3
Institutes: 1University of Athens, Dept. of Clinical Therapeutics, Athens, 2Aristotelion University, Dept. of Medical Oncology, Thessaloniki, 3Athens University, Clinical Therapeutics, Athens, 4Theagenion Hospital, Medical Oncology, Thessaloniki, 5Aristotelion University, Medical Oncology, Thessaloniki, 6Metropolitan Hospital, Medical Oncology, Athens, 7Athens University, Oncology Unit, Sotiria Hospital, Athens, 8Thessalia University, Medical Oncology, Larisa
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 341
  • Nr: P094

P102: Long-term outcome in patients refusing cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: A single institution experience

By:Atzori F.1, Ionta M.T.1, Deidda M.C.1, Dore A.2, Usai P.2, Barca M.1, Pusceddu V.1, De Lisa A.2, Scarpa R.M.3, Massidda B.1
Institutes: 1University of Cagliari, Dept. of Medical Oncology, Cagliari, 2University of Cagliari, Urologic Clinic, Cagliari, 3Azienda Ospedaliera Universitaria San Luigi Gonzaga, Urologic Clinic, Orbassano
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 328
  • Nr: P102

P052: Interfraction displacements of the prostate during an imrt session: What margins do we need?

By:Frascino V.1, Balducci M.1, Rinaldi C.G.1, Mantini G.1, D'agostino G.R.1, Mattiucci G.C.1, Dinapoli N.1, Fersino S.1, Tagliaferri L.1, Fidanzio A.2, Gambacorta M.A.1, Cellini N.1
Institutes: 1Catholic University Ot The Sacred Heart, Dept. of Radiation Oncology, Rome, 2Catholic University Ot The Sacred Heart, Dept. of Physics, Rome
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 332
  • Nr: P052

P058: High risk prostate cancer (Gleason score ≥ 8 and/or PSA ≥ 20 ng/mL): What is the role of radiation therapy associated with hormonal therapy?

By:Mantini G., De Dilectis G., Balducci M., Mattiucci G., Frascino V., Dinapoli N., Luzi L., Smaniotto D., Fersino S., Mazzeo E., Cellini N., Tagliaferri L.
Institutes: Univerità Cattolica Del Sacro Cuore, Dept. of Radiotherapy, Rome
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 337
  • Nr: P058

P061: ERK-1 and ERK-2 expression is related to serum prostate specific antigen (PSA) levels and prostate cancer progression

By:Chaves C.4, Bouraoui Y.R.2, Fraile B.1, Martínez-Onsurbe P.3, Rodriguez-Berriguete G.1, Paniagua R.1, Oueslati R.2, Royuela M.1, Olmedilla G.3
Institutes: 1University of Alcala, Dept. of Cell Biology and Genetics, Alcala De Henares. Madrid, 2Faculte Des Sciences De Bizerte, Unité D'immunologie, Bizerte, 3Hospital Principe De Asturias, Dept. of Pathology, Alcala De Henares. Madrid, 4University of Alcalá, Dept. Cell Biology and Genetics, Madrid
  • Event: 2nd European Multidisciplinary Meeting on Urological Cancers
  • Medium: Poster
  • Date: 29-11-2009
  • Views: 322
  • Nr: P061